Improved characterization of sub-centimeter enhancing breast masses on MRI with radiomics and machine learning in BRCA mutation carriers.
Improved characterization of sub-centimeter enhancing breast masses on MRI with radiomics and machine learning in BRCA mutation carriers.
复制标题
DOI:
10.1007/s00330-020-06991-7
复制
发表时间:
2020-12
影响因子:
5.9
通讯作者:
Pinker K
中科院分区:
文献类型:
--
作者:
Lo Gullo R;Daimiel I;Rossi Saccarelli C;Bitencourt A;Gibbs P;Fox MJ;Thakur SB;Martinez DF;Jochelson MS;Morris EA;Pinker K
To investigate whether radiomics features extracted from MRI of BRCA-positive patients with sub-centimeter breast masses can be coupled with machine learning to differentiate benign from malignant lesions using model-free parameter maps. In this retrospective study, BRCA-positive patients who had an MRI from November 2013 to February 2019 that led to a biopsy (BI-RADS 4) or imaging follow-up (BI-RADS 3) for sub-centimeter lesions were included. Two radiologists assessed all lesions independently and in consensus according to BI-RADS. Radiomics features were calculated using open-source CERR software. Univariate analysis and multivariate modeling were performed to identify significant radiomics features and clinical factors to be included in a machine learning model to differentiate malignant from benign lesions. Ninety-six BRCA mutation carriers (mean age at biopsy = 45.5 ± 13.5 years) were included. Consensus BI-RADS classification assessment achieved a diagnostic accuracy of 53.4%, sensitivity of 75% (30/40), specificity of 42.1% (32/76), PPV of 40.5% (30/74), and NPV of 76.2% (32/42). The machine learning model combining five parameters (age, lesion location, GLCM-based correlation from the pre-contrast phase, first-order coefficient of variation from the 1st post-contrast phase, and SZM-based gray level variance from the 1st post-contrast phase) achieved a diagnostic accuracy of 81.5%, sensitivity of 63.2% (24/38), specificity of 91.4% (64/70), PPV of 80.0% (24/30), and NPV of 82.1% (64/78). Radiomics analysis coupled with machine learning improves the diagnostic accuracy of MRI in characterizing sub-centimeter breast masses as benign or malignant compared with qualitative morphological assessment with BI-RADS classification alone in BRCA mutation carriers. • Radiomics and machine learning can help differentiate benign from malignant breast masses even if the masses are small and morphological features are benign. • Radiomics and machine learning analysis showed improved diagnostic accuracy, specificity, PPV, and NPV compared with qualitative morphological assessment alone. The online version of this article (10.1007/s00330-020-06991-7) contains supplementary material, which is available to authorized users.
登录
查看更多内容
DOI:
10.1200/jco.2014.56.8626
发表时间:
2015-04-01
期刊:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
影响因子:
--
作者:
Riedl CC;Luft N;Bernhart C;Weber M;Bernathova M;Tea MK;Rudas M;Singer CF;Helbich TH
通讯作者:
Helbich TH
影响因子:
19.7
作者:
Schrading, Simone;Kuhl, Christiane K.
通讯作者:
Kuhl, Christiane K.
影响因子:
2.6
作者:
Meissnitzer, Matthias;Dershaw, D. David;Morris, Elizabeth A.
通讯作者:
Morris, Elizabeth A.
影响因子:
3.3
作者:
Marino, Maria Adele;Riedl, Christopher C.;Pinker, Katja
通讯作者:
Pinker, Katja
影响因子:
158.5
作者:
Kriege, M;Brekelmans, CTM;Klijn, JGM
通讯作者:
Klijn, JGM